Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nesbit, T.
Right arrow Articles by Kvancz, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nesbit, T.
Right arrow Articles by Kvancz, D.
American Journal of Health-System Pharmacy, Vol 58, Issue 9, 784-790
Copyright © 2001 by American Society of Health-System Pharmacists

Articles

Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model

TW Nesbit, KM Shermock, MB Bobek, DL Capozzi, PA Flores, MC Leonard, JK Long, MA Militello, DA White, LD Barone, MP Goldman, and DA Kvancz


The implementation and pharmacoeconomic analysis of a clinical staff pharmacist (CSP) practice model are described. Staff pharmacists at a large, tertiary care, academic medical center were selected and trained to perform clinical pharmacy services under the direction of clinical pharmacy specialist mentors. Clinical interventions by these CSP practitioners were evaluated in terms of direct cost savings (the difference in actual acquisition costs between therapies) and cost avoidance (the dollar value of adverse drug events [ADEs] avoided). The CSPs performed a total of 4959 interventions during a 12-month period. The interventions provided direct cost savings of $92,076 and an estimated cost avoidance of $488,436. Comparing cost savings and cost avoidance with the expenses of providing these services indicated a net economic benefit of $392,660. A new model of pharmacy practice that integrates staff pharmacists into existing clinical practice has the potential to minimize the risks, decrease the costs, and improve the outcomes associated with drug therapy.
 



This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
T. De Rijdt, L. Willems, and S. Simoens
Economic effects of clinical pharmacy interventions: A literature review
Am. J. Health Syst. Pharm., June 15, 2008; 65(12): 1161 - 1172.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
B. J. Kopp, M. Mrsan, B. L. Erstad, and J. J. Duby
Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist
Am. J. Health Syst. Pharm., December 1, 2007; 64(23): 2483 - 2487.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
J. M. Ling, L. A. Mike, J. Rubin, P. Abraham, A. Howe, J. Patka, and D. Vigliotti
Documentation of pharmacist interventions in the emergency department
Am. J. Health Syst. Pharm., September 1, 2005; 62(17): 1793 - 1797.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Health-System Pharmacists.